Filings Received and Processed at the SEC

Aquestive Therapeutics, Inc.

1398733 ⦿ 0001398733-26-000022

Form 8-K Filer

Item 7.01: Regulation FD Disclosure

Item 9.01: Financial Statements and Exhibits

Magnum Ice Cream Co N.V.

2071668 ⦿ 0001171843-26-002007

Form 6-K Filer

Lord Abbett Corporate Opportunities Fund

1855299 ⦿ 0001410368-26-033606

Form 24F-2NT Filer

LORD ABBETT GLOBAL FUND INC

829901 ⦿ 0001410368-26-033608

Form 24F-2NT Filer

LORD ABBETT MID CAP STOCK FUND INC

716788 ⦿ 0001410368-26-033607

Form 24F-2NT Filer

Lord Abbett Credit Opportunities Fund

1753712 ⦿ 0001410368-26-033604

Form 24F-2NT Filer

LORD ABBETT BOND DEBENTURE FUND INC

60365 ⦿ 0001410368-26-033605

Form 24F-2NT Filer

Bingham Jonathan

2114369 ⦿ 0002114369-26-000010

Form 4 Reporting

HSBC HOLDINGS PLC

1089113 ⦿ 0002114369-26-000010

Form 4 Issuer

Tan Emily

2124715 ⦿ 0001140361-26-011864

Form 3 Reporting

Hafnia Ltd

1815779 ⦿ 0001140361-26-011864

Form 3 Issuer

Collective Mining Ltd.

1953575 ⦿ 0001279569-26-000239

Form 6-K Filer

Wolman Merrick Zane

2111376 ⦿ 0001011438-26-000210

Form 3 Reporting

Super Group

1878057 ⦿ 0001011438-26-000210

Form 3 Issuer

CGL Logistics Holdings Ltd

1934387 ⦿ 0001493152-26-013468

Form F-1/A Filer

ProCap Financial, Inc.

2076163 ⦿ 0001493152-26-013469

Form 8-K Filer

Item 4.01: Changes in Registrant's Certifying Accountant

Item 5.07: Submission of Matters to a Vote of Security Holders

Item 9.01: Financial Statements and Exhibits

Sensei Biotherapeutics, Inc.

1829802 ⦿ 0001193125-26-130419

Form 8-K Filer

Item 2.02: Results of Operations and Financial Condition

Item 9.01: Financial Statements and Exhibits

BofA Finance LLC

1682472 ⦿ 0001918704-26-008383

Form 424B2 Filer

BANK OF AMERICA CORP /DE/

70858 ⦿ 0001918704-26-008383

Form 424B2 Filer

Grubman Eric Peter

2124367 ⦿ 0001011438-26-000209

Form 3 Reporting

Super Group

1878057 ⦿ 0001011438-26-000209

Form 3 Issuer

Smart Share Global Ltd

1834253 ⦿ 0001104659-26-036470

Form 6-K Filer

Terrestrial Energy Inc. /DE/

2019804 ⦿ 0001104659-26-036467

Form 8-K Filer

Item 2.02: Results of Operations and Financial Condition

Item 9.01: Financial Statements and Exhibits

BofA Finance LLC

1682472 ⦿ 0001918704-26-008382

Form 424B2 Filer

BANK OF AMERICA CORP /DE/

70858 ⦿ 0001918704-26-008382

Form 424B2 Filer

Vine Hill Capital Investment Corp.

2025396 ⦿ 0001213900-26-035962

Form 8-K Filer

Item 3.01: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing

Item 5.07: Submission of Matters to a Vote of Security Holders

Item 8.01: Other Events

Item 9.01: Financial Statements and Exhibits

AGARWAL AJAY GIRIDHARILAL

2125339 ⦿ 0002125339-26-000002

Form 3 Reporting

HDFC BANK LTD

1144967 ⦿ 0002125339-26-000002

Form 3 Issuer

AURORA CANNABIS INC

1683541 ⦿ 0001279569-26-000238

Form 6-K Filer

Unicycive Therapeutics, Inc.

1766140 ⦿ 0001213900-26-035961

Form 8-K Filer

Item 2.02: Results of Operations and Financial Condition

Item 9.01: Financial Statements and Exhibits

BOEING CO

12927 ⦿ 0001193125-26-130412

Form DEFA14A Filer

Aura Biosciences, Inc.

1501796 ⦿ 0001193125-26-130408

Form S-8 Filer

CONTINENTAL STOCK TRANSFER & TRUST CO /TA

24179 ⦿ 0000024179-26-000004

Form TA-2/A Filer

BofA Finance LLC

1682472 ⦿ 0001918704-26-008381

Form 424B2 Filer

BANK OF AMERICA CORP /DE/

70858 ⦿ 0001918704-26-008381

Form 424B2 Filer

ECARX Holdings Inc.

1861974 ⦿ 0001628280-26-021865

Form 20-F Filer

USA Rare Earth, Inc.

1970622 ⦿ 0001970622-26-000021

Form 10-K Filer

Can-Fite BioPharma Ltd.

1536196 ⦿ 0001213900-26-035956

Form 6-K Filer

RYANAIR HOLDINGS PLC

1038683 ⦿ 0001654954-26-002923

Form 6-K Filer

NOCERA, INC.

1756180 ⦿ 0001683168-26-002366

Form NT 10-K Filer

Neumora Therapeutics, Inc.

1885522 ⦿ 0001193125-26-130407

Form S-8 Filer

BofA Finance LLC

1682472 ⦿ 0001918704-26-008380

Form 424B2 Filer

BANK OF AMERICA CORP /DE/

70858 ⦿ 0001918704-26-008380

Form 424B2 Filer

Regencell Bioscience Holdings Ltd

1829667 ⦿ 0001213900-26-035953

Form 6-K Filer

Carter Michael Phillip

2124688 ⦿ 0001493152-26-013464

Form 3 Reporting

Lucas GC Ltd

1954694 ⦿ 0001493152-26-013464

Form 3 Issuer

Fortis Inc.

1666175 ⦿ 0001104659-26-036461

Form 6-K Filer

Phio Pharmaceuticals Corp.

1533040 ⦿ 0001437749-26-010164

Form 8-K Filer

Item 8.01: Other Events

Aura Biosciences, Inc.

1501796 ⦿ 0001193125-26-130401

Form 10-K Filer

ATMOS ENERGY CORP

731802 ⦿ 0001193125-26-130403

Form 8-K Filer

Item 1.01: Entry into a Material Definitive Agreement

Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant

BOSTON SCIENTIFIC CORP

885725 ⦿ 0001104659-26-036456

Form S-4/A Filer

Wong Wang-chan

2124918 ⦿ 0001493152-26-013462

Form 3 Reporting

Lucas GC Ltd

1954694 ⦿ 0001493152-26-013462

Form 3 Issuer

Wegerer Jeremy

2124914 ⦿ 0001493152-26-013460

Form 3 Reporting

Lucas GC Ltd

1954694 ⦿ 0001493152-26-013460

Form 3 Issuer

USA Rare Earth, Inc.

1970622 ⦿ 0001970622-26-000019

Form 8-K Filer

Item 2.02: Results of Operations and Financial Condition

Item 9.01: Financial Statements and Exhibits

Regencell Bioscience Holdings Ltd

1829667 ⦿ 0001213900-26-035946

Form 6-K Filer

Eikon Therapeutics, Inc.

1861123 ⦿ 0001193125-26-130395

Form 10-K Filer

Capstone Green Energy Holdings, Inc.

1009759 ⦿ 0001104659-26-036455

Form 8-K Filer

Item 1.01: Entry into a Material Definitive Agreement

Item 3.02: Unregistered Sales of Equity Securities

Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year

Item 7.01: Regulation FD Disclosure

Item 9.01: Financial Statements and Exhibits

SportsQuest, Inc.

803097 ⦿ 0001683168-26-002363

Form 10-K Filer

Neumora Therapeutics, Inc.

1885522 ⦿ 0001193125-26-130388

Form 10-K Filer

Sight Sciences, Inc.

1531177 ⦿ 0001193125-26-130386

Form 8-K Filer

Item 7.01: Regulation FD Disclosure

Item 9.01: Financial Statements and Exhibits

MOLECULAR PARTNERS AG

1745114 ⦿ 0001745114-26-000015

Form 6-K Filer

Helio Corp /FL/

1953988 ⦿ 0001213900-26-035941

Form 10-Q Filer

Connect Biopharma Holdings Ltd

1835268 ⦿ 0001835268-26-000006

Form 8-K Filer

Item 1.01: Entry into a Material Definitive Agreement

Item 3.02: Unregistered Sales of Equity Securities

Item 7.01: Regulation FD Disclosure

Item 8.01: Other Events

Item 9.01: Financial Statements and Exhibits

PDS Biotechnology Corp

1472091 ⦿ 0001140361-26-011862

Form 8-K Filer

Item 2.02: Results of Operations and Financial Condition

Item 9.01: Financial Statements and Exhibits

Argo Blockchain Plc

1841675 ⦿ 0001654954-26-002921

Form 6-K Filer

Aura Biosciences, Inc.

1501796 ⦿ 0001193125-26-130383

Form 8-K Filer

Item 2.02: Results of Operations and Financial Condition

Item 8.01: Other Events

Item 9.01: Financial Statements and Exhibits

Basel Medical Group Ltd

2004489 ⦿ 0001493152-26-013458

Form 6-K Filer

Cytosorbents Corp

1175151 ⦿ 0001104659-26-036451

Form 10-K Filer

Mordehachvili Thiago

2115381 ⦿ 0001628280-26-021862

Form 3/A Reporting

Borr Drilling Ltd

1715497 ⦿ 0001628280-26-021862

Form 3/A Issuer

Lozinski Jeffrey William

2016329 ⦿ 0001683168-26-002358

Form 4 Reporting

Kinetic Seas Inc.

1945619 ⦿ 0001683168-26-002358

Form 4 Issuer

SPIRE INC

1126956 ⦿ 0001193125-26-130379

Form 8-K Filer

Item 1.01: Entry into a Material Definitive Agreement

Item 7.01: Regulation FD Disclosure

Item 9.01: Financial Statements and Exhibits

PMGC Holdings Inc.

1840563 ⦿ 0001213900-26-035937

Form 10-K Filer

PSNH FUNDING LLC 3

1730300 ⦿ 0001104659-26-036446

Form 10-K Filer

UNITED THERAPEUTICS Corp

1082554 ⦿ 0001104659-26-036445

Form 8-K Filer

Item 8.01: Other Events

Item 9.01: Financial Statements and Exhibits

BRBI BR Partners S.A.

2058601 ⦿ 0001213900-26-035936

Form 6-K Filer

Coronado Global Resources Inc.

1770561 ⦿ 0001104659-26-036444

Form 8-K Filer

Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

Item 9.01: Financial Statements and Exhibits

Citigroup Global Markets Holdings Inc.

200245 ⦿ 0001918704-26-008379

Form FWP Subject

Soluna Holdings, Inc

64463 ⦿ 0001493152-26-013456

Form 8-K Filer

Item 2.02: Results of Operations and Financial Condition

Item 7.01: Regulation FD Disclosure

Item 9.01: Financial Statements and Exhibits

Vertical Aerospace Ltd.

1867102 ⦿ 0001104659-26-036443

Form 6-K Filer

Neumora Therapeutics, Inc.

1885522 ⦿ 0001193125-26-130372

Form 8-K Filer

Item 2.02: Results of Operations and Financial Condition

Item 9.01: Financial Statements and Exhibits

CITIGROUP INC

831001 ⦿ 0001918704-26-008378

Form FWP Subject

Atlanta Zion Peachtree City Roland Park LLC

2124988 ⦿ 0002124988-26-000001

Form D Filer

Agencia Comercial Spirits Ltd.

2060016 ⦿ 0001213900-26-035933

Form 6-K Filer

Zhou Yahui

1768074 ⦿ 0001737450-26-000007

Form SCHEDULE 13D/A Filed by

Opera Ltd

1737450 ⦿ 0001737450-26-000007

Form SCHEDULE 13D/A Subject

GoldMining Inc.

1538847 ⦿ 0001437749-26-010155

Form 6-K Filer

GSK plc

1131399 ⦿ 0001654954-26-002919

Form 6-K Filer

Ellomay Capital Ltd.

946394 ⦿ 0001213900-26-035929

Form 6-K Filer

First American Financial Corp

1472787 ⦿ 0001193125-26-130354

Form ARS Filer

Empire Fortune Management Ltd

2112712 ⦿ 0002112712-26-000003

Form SCHEDULE 13D/A Filed by

ATA Creativity Global

1420529 ⦿ 0002112712-26-000003

Form SCHEDULE 13D/A Subject

Sable Offshore Corp.

1831481 ⦿ 0001831481-26-000032

Form 8-K Filer

Item 7.01: Regulation FD Disclosure

Item 9.01: Financial Statements and Exhibits

FOK Pak Kin Charles

2121895 ⦿ 0001213900-26-035927

Form 3 Reporting

Raytech Holding Ltd

1948443 ⦿ 0001213900-26-035927

Form 3 Issuer

JPMorgan Chase Financial Co. LLC

1665650 ⦿ 0001213900-26-035924

Form 424B2 Filer

JPMORGAN CHASE & CO

19617 ⦿ 0001213900-26-035924

Form 424B2 Filer